Ehesan U Sharif

6PUBLICATIONS
9CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 23, 2025
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy.

Dillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu

|May 23, 2025
Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors.

Corinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu

|Oct 21, 2021
Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).

Guillaume Mata, Dillon H Miles, Samuel L Drew

|Jan 05, 2021
Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.

Ehesan U Sharif, Jaroslaw Kalisiak, Kenneth V Lawson

|Sep 01, 2020
Discovery of Potent and Selective PI3Kγ Inhibitors.

Samuel L Drew, Rhiannon Thomas-Tran, Joel W Beatty

|Jul 03, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73.

Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey

Pageof 1

Frequent Collaborators

4 joint publications

Kenneth V Lawson

3 joint publications

Jenna L Jeffrey

2 joint publications

Brandon R Rosen

2 joint publications

Norbert Sträter